Epstein–Barr Virus: Human Interactome Reveals New Molecular Insights into Viral Pathogenesis for Potential Therapeutics and Antiviral Drug Discovery
OMICS: A Journal of Integrative Biology · 2024
DOI: 10.1089/omi.2023.0241 ↗Kurz gefasst
Fachartikel in der Zeitschrift OMICS: A Journal of Integrative Biology, 2024. Verfasst von Deepak Krishnan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Systems Biology and Molecular Medicine (CSBMM), Yenepoya Research Centre (YRC), Yenepoya (Deemed to be University), Mangalore, India. Hauptthemen laut MEDLINE: Epstein-Barr Virus Infections, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 81 Literaturangaben.
Abstract (Originalsprache)
Host-virus Protein–Protein Interactions (PPIs) play pivotal roles in biological processes crucial for viral pathogenesis and by extension, inform antiviral drug discovery and therapeutics innovations. Despite efforts to develop the Epstein–Barr virus (EBV)-host PPI network, there remain significant knowledge gaps and a limited number of interacting human proteins deciphered. Furthermore, understanding the dynamics of the EBV-host PPI network in the distinct lytic and latent viral stages remains elusive. In this study, we report a comprehensive map of the EBV–human protein interactions, encompassing 1752 human and 61 EBV proteins by integrating data from the public repository HPIDB (v3.0) as well as curated high-throughput proteomic data from the literature. To address the stage-specific nature of EBV infection, we generated two detailed subset networks representing the latent and lytic stages, comprising 747 and 481 human proteins, respectively. Functional and pathway enrichment analysis of these subsets uncovered the profound impact of EBV proteins on cancer. The identification of highly connected proteins and the characterization of intrinsically disordered and cancer-related proteins provide valuable insights into potential therapeutic targets. Moreover, the exploration of drug–protein interactions revealed notable associations between hub proteins and anticancer drugs, offering novel perspectives for controlling EBV pathogenesis. This study represents, to the best of our knowledge, the first comprehensive investigation of the two distinct stages of EBV infection using high-throughput datasets. This makes a contribution to our understanding of EBV–host interactions and provides a foundation for future drug discovery and therapeutic interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Systems Biology and Molecular Medicine (CSBMM), Yenepoya Research Centre (YRC), Yenepoya (Deemed to be University), Mangalore, India.
- Centre for Integrative Omics Data Science (CIODS), Yenepoya (Deemed to be University), Mangalore, India.
- Institute of Advanced Virology, Bio 360 Life Sciences Park, Thiruvananthapuram, India.
ORCID-Profile: Rajesh Raju, Thottethodi Subramanya Keshava Prasad, Chandran S Abhinand
Zitieren
APA
Krishnan, D., Babu, S., Raju, R., Veettil, M. V., Prasad, T. S. K., & Abhinand, C. S. (2024). Epstein–Barr Virus: Human Interactome Reveals New Molecular Insights into Viral Pathogenesis for Potential Therapeutics and Antiviral Drug Discovery. OMICS: A Journal of Integrative Biology. https://doi.org/10.1089/omi.2023.0241
Vancouver
Krishnan D, Babu S, Raju R, Veettil MV, Prasad TSK, Abhinand CS. Epstein–Barr Virus: Human Interactome Reveals New Molecular Insights into Viral Pathogenesis for Potential Therapeutics and Antiviral Drug Discovery. OMICS: A Journal of Integrative Biology. 2024. doi:10.1089/omi.2023.0241
BibTeX
@article{Krishnan2024,
author = {Krishnan, Deepak and Babu, Sreeranjini and Raju, Rajesh and Veettil, Mohanan Valiya and Prasad, Thottethodi Subramanya Keshava and Abhinand, Chandran S},
title = {Epstein–Barr Virus: Human Interactome Reveals New Molecular Insights into Viral Pathogenesis for Potential Therapeutics and Antiviral Drug Discovery},
journal = {OMICS: A Journal of Integrative Biology},
year = {2024},
doi = {10.1089/omi.2023.0241}
}
EUVIMED